Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.prrv.2020.06.010 http://scihub22266oqcxt.onion/10.1016/j.prrv.2020.06.010 32653463!7301825!32653463     free     free     free       Paediatr+Respir+Rev 2020 ; 35 (ä): 43-49 Nephropedia Template TP {{tp|p=32653463|t=2020. Vaccines for COVID-19: The current state of play |pdf=|usr=}}{{32653463}} gab.com Text Vaccines for COVID-19: The current state of play JO: Paediatr Respir Rev http://www.kidney.de/pget.php?&tw=1&pmid=32653463 #FOAvip There is a strong consensus globally that a COVID-19 vaccine is likely the most effective approach to sustainably controlling the COVID-19 pandemic. An unprecedented research effort and global coordination has resulted in a rapid development of vaccine candidates and initiation of trials. Here, we review vaccine types, and progress with 10 vaccine candidates against SARS-CoV-2 - the virus that causes COVID-19 - currently undergoing early phase human trials. We also consider the many challenges of developing and deploying a new vaccine on a global scale, and recommend caution with respect to our expectations of the timeline that may be ahead. Twit Text FOAVip Vaccines for COVID-19: The current state of play ????Paediatr Respir Rev http://www.kidney.de/pget.php?&tw=1&pmid=32653463 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32653463 #FOAvip English Wikipedia <ref>{{Cite pmid|32653463}}</ref> Vaccines for COVID-19: The current state of play #MMPMID32653463 Koirala A; Joo YJ; Khatami A; Chiu C; Britton PN Paediatr Respir Rev 2020[Sep]; 35 (ä): 43-49 PMID32653463show ga There is a strong consensus globally that a COVID-19 vaccine is likely the most effective approach to sustainably controlling the COVID-19 pandemic. An unprecedented research effort and global coordination has resulted in a rapid development of vaccine candidates and initiation of trials. Here, we review vaccine types, and progress with 10 vaccine candidates against SARS-CoV-2 - the virus that causes COVID-19 - currently undergoing early phase human trials. We also consider the many challenges of developing and deploying a new vaccine on a global scale, and recommend caution with respect to our expectations of the timeline that may be ahead. |Betacoronavirus/*immunology[MESH] |COVID-19[MESH] |COVID-19 Vaccines[MESH] |Clinical Trials as Topic[MESH] |Coronavirus Infections/immunology/*prevention & control[MESH] |Drug Development[MESH] |Humans[MESH] |Middle East Respiratory Syndrome Coronavirus/immunology[MESH] |Pandemics/*prevention & control[MESH] |Pneumonia, Viral/*prevention & control[MESH] |SARS-CoV-2[MESH] |Severe acute respiratory syndrome-related coronavirus/immunology[MESH] |Vaccines, DNA/immunology/*therapeutic use[MESH] |Vaccines, Synthetic/immunology/*therapeutic use[MESH]Vaccines for COVID-19: The current state of play (epmc).pdf DeepDyve Pubget Overpricing